Tactile Systems Technology Inc
$ 24.41
1.79%
02 Jun - close price
- Market Cap 540,899,000 USD
- Current Price $ 24.41
- High / Low $ 24.82 / 23.77
- Stock P/E 27.56
- Book Value 9.59
- EPS 0.87
- Next Earning Report 2026-08-03
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.10 %
- 52 Week High 37.77
- 52 Week Low 9.41
About
Tactile Systems Technology, Inc., a medical technology company, is dedicated to the development and supply of medical devices for chronic diseases in the United States. The company is headquartered in Minneapolis, Minnesota.
Analyst Target Price
$39.50
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-04 | 2026-02-17 | 2025-11-03 | 2025-08-04 | 2025-05-05 | 2025-02-18 | 2024-11-04 | 2024-08-05 | 2024-05-06 | 2024-02-20 | 2023-11-06 | 2023-08-07 |
| Reported EPS | 0.0024 | 0.46 | 0.36 | 0.14 | -0.11 | 0.397 | 0.25 | 0.2 | -0.05 | 0.35 | 0.85 | 0.04 |
| Estimated EPS | -0.04 | 0.445 | 0.21 | 0.14 | -0.06 | 0.28 | 0.17 | 0.14 | -0.01 | 0.19 | 0.02 | -0.02 |
| Surprise | 0.0424 | 0.015 | 0.15 | 0 | -0.05 | 0.117 | 0.08 | 0.06 | -0.04 | 0.16 | 0.83 | 0.06 |
| Surprise Percentage | 106% | 3.3708% | 71.4286% | 0% | -83.3333% | 41.7857% | 47.0588% | 42.8571% | -400% | 84.2105% | 4150% | 300% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-03 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.17 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TCMD
2026-06-02 12:09:55
Tactile Medical has launched its next-generation AffloVest high-frequency chest wall oscillation (HFCWO) therapy system, designed to enhance patient comfort and adherence for those with chronic neuromuscular and respiratory conditions. The updated system features reduced weight, expanded size adjustability, and built-in Wi-Fi and Bluetooth connectivity for improved patient experience and data-driven clinical insights. This innovation aims to provide a more comfortable and connected therapy solution while maintaining clinical effectiveness.
2026-06-02 12:09:55
Tactile Medical has launched its next-generation AffloVest, an airway clearance system designed for patients with chronic neuromuscular and respiratory conditions such as cystic fibrosis and bronchiectasis. The new device is lighter, more adjustable, and includes built-in Wi-Fi and Bluetooth for connected care, aiming to improve patient comfort, ease of use, and therapy adherence. These enhancements also provide clinicians and DME providers with real-world therapy data to support patient care and reimbursement.
2026-05-30 01:10:18
Tactile Systems Technology Inc (TCMD) shares dropped 3.5% to $24.61, yet GuruFocus assesses the stock as significantly overvalued with a current price 32.9% above its GF Value™ estimate of $18.52. Despite a strong GF Score™ of 82/100, driven by high financial strength and momentum, its valuation score is low, and recent insider selling further suggests caution for investors. The company's P/E ratio of 28.0x is 26% higher than its 5-year median, reinforcing the overvalued assessment.
2026-05-21 20:10:13
BTIG has reiterated a "Buy" rating on Tactile Systems Tech (TCMD), maintaining a price target of $40.00, indicating strong analyst confidence despite the stock being identified as 34.7% overvalued by GuruFocus's GF Value™. TCMD boasts a high GF Score™ of 82/100, driven by strong financial strength and momentum, but its high P/E ratio and recent insider selling suggest investors should proceed with caution regarding its current valuation.
2026-05-21 12:16:18
BTIG Research has reiterated a "Buy" rating for Tactile Systems Technology (NASDAQ:TCMD) and maintained a $40 price target, suggesting a potential 61% upside. Other analysts also have a "Moderate Buy" consensus with an average target of $38.60. The company recently reported mixed quarterly results, missing EPS estimates but exceeding revenue expectations, with shares trading around $24.84.
2026-05-21 08:08:59
UBS Group AG significantly reduced its stake in Tactile Systems Technology ($TCMD) by selling 168,372 shares, ending with 197,715 shares valued at $5.7 million. Despite this, analyst sentiment remains positive with a "Moderate Buy" rating and a $38.60 average price target. The company also saw recent insider selling by its CEO and VP, missed EPS estimates, but exceeded revenue expectations in its latest quarter.
